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membranes leading to decreases in
active GTP-bound ARF1.
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Lipogenesis requires coordinated expression of
genes for fatty acid, phospholipid, and triglyceride
synthesis. Transcription factors, such as SREBP-1
(Sterol regulatory element binding protein), may be
activated in response to feedback mechanisms link-
ing gene activation to levels of metabolites in the
pathways. SREBPs can be regulated in response
to membrane cholesterol and we also found that
low levels of phosphatidylcholine (a methylated
phospholipid) led to SBP-1/SREBP-1 maturation in
C. elegans or mammalian models. To identify addi-
tional regulatory components, we performed a tar-
geted RNAi screen in C. elegans, finding that both
lpin-1/Lipin 1 (which converts phosphatidic acid to
diacylglycerol) and arf-1.2/ARF1 (a GTPase regu-
lating Golgi function) were important for low-PC acti-
vation of SBP-1/SREBP-1. Mechanistically linking
the major hits of our screen, we find that limiting
PC synthesis or LPIN1 knockdown in mammalian
cells reduces the levels of active GTP-bound ARF1.
Thus, changes in distinct lipid ratios may converge
on ARF1 to increase SBP-1/SREBP-1 activity.INTRODUCTION
Metabolic gene regulation is often connected to products or sub-
strates in the pathway. In some cases, such as low-cholesterol
stimulated maturation of SREBP (sterol regulatory element
binding protein) transcription factors, mechanisms have been
described in detail. SREBPs reside in the endoplasmic reticulum
(ER) as membrane intrinsic, inactive precursors (Osborne and
Espenshade, 2009). Drops in intra-membrane cholesterol pro-
mote transport of SREBP to the Golgi (Goldstein et al., 2006)
where proteases release the transcriptionally active portion
(Brown and Goldstein, 1997). SREBPs regulate genes required
for fatty acid, TAG (triglyceride), PC (phosphatidylcholine), and
cholesterol synthesis (Horton et al., 2002); therefore, it is not sur-
prising that control of SREBP activity is complex and responds
to a variety of metabolic signals. SREBP-2 is tightly linked to
cholesterol synthesis, whereas the SREBP-1a/c isoforms haveThis is an open access article under the CC BY-Nbroader roles (Horton, 2002). Using C. elegans and mammalian
models, we previously found that low levels of SAM acted
through PC to induce cholesterol-independent SREBP-1 pro-
cessing (Walker et al., 2011). Instead of depending on COP II
transit to the ER, low PCwas associated with dissolution of Golgi
markers, suggesting SREBP-activating proteases may cleave
ER bound SREBP-1, as in Brefeldin-A mediated activation
(DeBose-Boyd et al., 1999). However, regulatory factors linking
PC to these processes were unclear.
To identify additional factors in this pathway, we performed a
C. elegans RNAi screen using the SBP-1/SREBP-1 responsive
reporter. Our genetic approach identified lpin-1/LPIN1 and arf-
1.2/ARF1, suggesting that, like cholesterol-dependent regula-
tion of SREBP-2, low-PC effects on SREBP-1 are linked to
effects of membrane lipids on intracellular transport; however,
in this case, intermediates in the TAG/PC synthesis pathway,
such as PA and DAG, may affect Golgi to ER COP I function.RESULTS
Targeted RNAi Screen to Reveal Low-PC Modulators
of SBP-1
To identify components in low-PC activation of SBP-1/SREBP-1,
we performed a targeted RNAi screen comparing activation of a
SBP-1-dependent reporter, pfat-7::GFP, in wild-type and low-
PC conditions. fat-7 encodes a stearoyl-CoA desaturase (SCD)
regulated by SBP-1 (Yang et al., 2006). Depletion of PC synthesis
enzymes (sams-1, pmt-1, cept-1, pcyt-1), stimulates SBP-1 and
fat-7 levels increase (Walker et al., 2011) (Figure 1A). We focused
onmetabolic pathways producing or utilizing PC, genes involved
in lipid-based signaling, and a subset of genes linked to COP I or
II transport. Next, we selected an RNAi sublibrary from the
ORFeome collection (Rual et al., 2004), the Ahringer library
(Kamath et al., 2003), or constructed RNAi targeting vectors
(Table S1). We screened for candidates satisfying two criteria:
first, necessary for pfat-7::GFP induction in low-PC sams-1(lof)
animals, and second, sufficient to activate pfat-7::GFP in wild-
type phospholipid levels (Figure 1B).
We screened four library replicates and divided candidates
into four classes according to GFP expression and genotype
(Figure 1B; Table S1). Class 1 or class 2 genes limited or
increased pfat-7::GFP expression and comprised 49 (23%) or
10 (5%) of clones screened. Candidate class 3 genes were asso-
ciated with decreases in sams-1(lof); pfat-7::GFP (68 genes), andCell Reports 16, 9–18, June 28, 2016 ª 2016 The Authors. 9
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Figure 1. Targeted RNAi Screen to Identify Modulators of SBP-1/SREBP-1 Activation in Low PC Conditions in C. elegans
(A) Schematic representation of low-phosphatidylcholine (PC)-based SBP-1/SREBP-1 activation in C. elegans.
(B) Schematic representation of RNAi screen designed to distinguish factors necessary and sufficient for low-PC based SBP-1 activation (classes 2 and 3) from
those generally required for SBP-1 function (classes 1 and 3).
(C) Heatmap showing genes which downregulate fat-7 expression in both pfat-7::GFP and sams-1(lof);pfat-7::GFP animals.
(D) Heatmap showing genes increasing fat-7 expression in pfat-7::GFP animals, while reducing GFP expression in sams-1(lof);pfat-7::GFP animals.
(E) Color bar representing averaged GFP scores represented by yellow (high) and by blue (low).
(F and G) Epifluorescence imaging showing RNAi of class 2/3 candidates in pfat-7::GFP (F) or sams-1(lof);pfat-7::GFP (G) in young adult C. elegans.
Scale bar, 75 mm. See also Table S1 and Figure S1.
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there were no genes that increased pfat-7::GFP in sams-1(lof)
animals (class 4). Class 1 and class 3 genes are predicted to
be generally important for SBP-1 function and indeed include
many regulators of classical SREBP-1 processing such as
scp-1 (SCAP, SREBP cleavage-activating protein) and the
COP II components such as sec-23, sec-24.1, and sar-1 (Fig-
ure 1C, red lettering). As in our previous data, PC synthesis
genes (pcyt-1 and cept-1) (Figure 1D, red labeling) fell into class 2
(Walker et al., 2011). Genes necessary for low-PC processing
and sufficient to activate SBP-1 in normal PC (Figure 1D, red
lettering) were predicted to lie in the intersection of candidate
classes 2 and 3. The GTPase arf-1.2 was present in this cate-
gory, aswell a phospholipase C ortholog. However, the PA phos-
phatase lpin-1 (Reue, 2007) showed the most striking increase in
pfat-7::GFP combined with decrease in sams-1(lof);pfat-7::GFP
(Figures 1D–1G; Table S1).
Next, we used qRT-PCR to determine expression of gfp,
endogenous fat-7 and fat-5 (another SBP-1 responsive gene)
in the reporter strain and also analyzed fat-7 and fat-5 expression
in wild-type animals. First, we confirmed that five of the top ten
class 1 genes were necessary for pfat-7::GFP mRNA expression
(see Table S1; see columns K–M for validation). For class 2
genes, we found that only lpin-1, arf-1.2, and plc-1 RNAi
increased gfp, endogenous fat-7 and fat-5mRNA levels (Figures
S1B and S1D). lpin-1, arf-1.2, and plc-1RNAi also decreased gfp
levels in the low-PC sams-1(lof);pfat-7::GFP (Figures S1C and
S1E). Finally, while lpin-1 and arf-1.2 RNAi increased endoge-
nous fat-7 and fat-5 in wild-type worms, plc-1 effects occurred
only in the transgenic strain (Figure S1D). We also noted that
sams-1(lof) animals with reduced lpin-1 showed additional phe-
notypes, including slowed development and synthetic lethality
(Figure S1G).
The importance of lpin-1 for low-PC activation pfat-7::GFP
prompted us to examine pathways producing the LPIN-1 sub-
strate, PA.C. elegans contains multiple paralogs of PA synthesis
genes (Figure S1A): three GPATs, acl-4, -5 and -6 and two
AGPATs, acl-11 and acl-13 (Ohba et al., 2013). Our screen
data showed that one GPAT (acl-4) and one AGPAT (acl-11)
were required for pfat-7::GFP expression in wild-type, but not
in sams-1(lof) animals (Figure 1C). In validation assays, we found
GFP was lower after acl-4 or acl-11 RNAi (Figure S2A), as were
gfp and endogenous fat-7 mRNA levels (Figure S2B). pfat7::gfp
or endogenous fat-7 gene expression was not altered by acl-4
and acl-11 RNAi in low-PC (sams-1(lof); pfat-7::GFP) conditions
(Figures S2C and S2D).
sams-1 or lpin-1 RNAi Reduce DAG and Change PA/PC
Ratios in C. elegans Microsomal Membranes
Loss of sams-1 decreases PC and increases TAG (Ding et al.,
2015; Walker et al., 2011); however, lpin-1 knockdown is pre-
dicted to affect PA and DAG (Figure S1A). To generate lipid
profiles in membranes linked to SBP-1/SREBP-1 processing,
we profiled microsomal lipids from sams-1 or lpin-1 RNAi
animals. We validated fractionations by immunoblotting with
C. elegans ER or Golgi specific antibodies (Figure S3A). LC/MS
analysis identified over 1,600 lipid species in over 20 classes
(Table S2). Principal component analysis shows that control,
sams-1, and lpin-1 RNAi samples are distinct and that biologicalreplicates are similar (Figure S3B). We analyzed the data in two
ways: first, values for lipid species were totaled for each class
and second, the distribution of species within each class was
determined. In sams-1(RNAi) microsomal fractions, we found
that TAGs as a class were increased and PCs as a class were
decreased (Figures S2C and S2D; see Table S2 for statistics),
as in our previous studies analyzing whole-worm extracts by
GC/MS (Ding et al., 2015; Walker et al., 2011). Many other lipid
species also changed (Figure S3E; Table S2), perhaps in
response to synthetic links between PC and other lipids. We
were surprised to see that DAG as a class was similar to wild-
type; however, many individual species shifted significantly
lower and the distribution of species within the class differed
significantly after sams-1(RNAi) (Figure S3F; Table S2). This is
in contrast to models for PC metabolism that predict increased
DAG when PC synthesis is blocked (Sarri et al., 2011) and may
reflect the specific nature of our assay.
lpin-1 RNAi, on the other hand, had fewer overall effects,
primarily lowering levels of many DAG species and increasing
multiple PA species (Figures S3F–S3I; see Table S2 for statis-
tics), consistent with a role for lpin-1 as a PA phosphatase.
Finally, we noted two major similarities in sams-1 and lpin-1 lipid
profiles. First, ratios of PA/PC species were elevated, and, sec-
ond, the distribution of species within the DAG class shifted
significantly lower. This is consistent with our genetic evidence
implicating enzymes directly liked to PA, DAG, and PC in the
regulation of pfat-7::GFP.
lpin-1 and arf-1.2 Are Important for low-PC Effects on
SBP-1
Increased fat-7 expression after lpin-1 RNAi suggests SBP-1
may be more active. To determine whether maturation was
stimulated, we examined subcellular localization of intestinal
GFP::SBP-1 (Walker et al., 2010). Similar to sams-1RNAi, knock-
down of either lpin-1 or arf-1.2 resulted in increased nuclear
levels of GFP::SBP-1 (Figure 2A), along with increases in fat-7
and fat-5 (Figure 2B). Interestingly, we noted that lpin-1 expres-
sion was slightly increased after sams-1 RNAi (Figure 2B; see
also Ding et al., 2015). Finally, depletion of PA synthesis enzymes
acl-4 and acl-11 had opposite effects, decreasing nuclear SBP-1
(Figures S2E–S2G).
Next, we performed Sudan Black staining to gauge size and
distribution of lipid droplets and measured TAG for total levels.
To avoid confounding results from the developmental delay of
sams-1(lof); lpin-1(RNAi) animals (Figure S1G), PC production
was rescued with choline until the L3 stage (Ding et al., 2015);
growth without choline after L3 was sufficient to increase SBP-
1-dependent gene expression (Figure S1H). lpin-1 RNAi animals
appeared clear with slightly reduced Sudan Black staining (Fig-
ures 2C and 2D), consistent with reports of decreased Nile
Red (Golden et al., 2009; Zhang et al., 2013); however, TAG
stores were not reduced in colorometric assays (Figure 2E) or
microsomal extracts (Table S2, see tab:TG.class). This suggests
other mechanisms may compensate for LPIN-1 function in TAG
synthesis. Importantly, large lipid droplets in sams-1(lof) animals
decreased upon lpin-1RNAi and TAG returned close towild-type
levels (Figures 2C–2E). Thus, interference with both sams-1 and
lpin-1 rescues effects of low-PC on stored lipids.Cell Reports 16, 9–18, June 28, 2016 11
Figure 2. In C. elegans, lpin-1 and arf-1.2 RNAi Increase Nuclear Localization of SBP-1::GFP and Are Important for Lipid Accumulation in
sams-1(lof) Animals
(A) Confocal projection showing nuclear accumulation of intestinal GFP::SBP-1 after sams-1, lpin-1, or arf-1.2 RNAi. Scale bar, 10 mm.
(B) qRT-PCR showing upregulation of fat-5 and fat-7.
(C–E) Lipid accumulation when sams-1 and lpin-1where co-depleted assessed by Sudan Black staining (C) with quantitation of percent of animals stained (D) or
TAG level (E). Scale bar for Sudan Black, 25 mm.
(F–H) For sams-1 and arf-1.2 co-depletion, Sudan Black staining and quantitation are in (F) and (G), and TAGmeasurements are in (H). Number of animals is shown
in parentheses.
Error bars show SD. Results from Student’s t test shown by *p < 0.05, **p < 0.01, ***p < 0.005. See also Table S2 and Figure S2.
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arf-1.2 knockdown also increased fat-7 expression and nu-
clear localization of GFP::SBP-1 (Figures 2A and 2B). Therefore,
we assessed Sudan Black staining and TAG levels. arf-1.2(RNAi)
worms had an increase in lipid droplets (Figures 2F and 2G);
however, TAG levels were only slightly higher than wild-type
(Figure 2H), suggesting effects on droplets size and not total
lipid levels. This is consistent with reports of ARF function in lipid
droplet formation (Wilfling et al., 2014). In contrast, arf-1.2 RNAi
reduced lipid droplet appearance, number, and overall TAG
levels in sams-1(lof) animals. Taken together, our C. elegans
studies show that reducing function of LPIN-1, an enzyme con-
verting PA to DAG, limits low-PC activation of SBP-1/SREBP.
Thus, enzymes that produce or utilize PA may be a key to this
mechanism.
LPIN1 Knockdown Is Sufficient to Activate Mammalian
SREBP-1 and Necessary for Low-PC Effect
In mammals, interference with PC synthesis results in hepatos-
teatosis (Vance, 2014), as SREBP-1-dependent lipogenesis pro-
grams are stimulated (Walker et al., 2011). To determine whether
Lipin 1 was required for activation ofmammalian SREBP-1 in this
context, we depleted LPIN1 with small interfering RNA (siRNA).
Like knockdown of PCTY1a/CCTa, the rate limiting enzyme in
mammalian PC production, LPIN1 depletion increased levels
of mature, nuclear SREBP-1 (Figures 3A–3C). LPIN1 knockdown
also increased nuclear localization and proteolytic maturation of
a N-terminal HA tagged SREBP-1 (Figure 3D; Figures S4A and
S4B). siRNA-mediated depletion was confirmed by qRT-PCR
and immunoblots from Dignam extracts of HepG2 cells (Figures
S4C and S4D).
To determine whether LPIN1 function was important for low-
PC effects on SREBP-1, we used siRNA to deplete both PCTY1a
and LPIN1 in HA-SREBP-1 lines. For combined siRNA, we kept
RNA amounts constant with scrambled control and achieved
efficient knockdown for both PCTY1a and LPIN1 (Figure S4C).
We found that nuclear HA-SREBP-1 localization was lost in
PCTY1a /LPIN1 double knockdowns (Figures 3D and 3F), sug-
gesting that, as in C. elegans, LPIN1 knockdown abrogates
the low-PC effect on SREBP-1. Similar effects were seen with
endogenous SREBP-1 (Figures S4E and S4F).
Lipin 1 converts PA to DAG, thus lower activity predicts in-
creases in PA (Takeuchi and Reue, 2009). To determine whether
exogenous PA could recapitulate LPIN1effects, we treated HA-
SREBP-1 cells with PA and found that indeed, SREBP-1 nuclear
accumulation increased (Figures 3E and 3G). Further paralleling
LPIN1 knockdown, PA decreased nuclear SREBP-1 in PCTY1a
siRNA cells (Figures 3E and 3G). Although effects of exogenous
PA on cultured cells may be complex and have species depen-
dent effects, changes in SREBP-1 maturation are consistent
with effects of LPIN1 knockdown. We also investigated low-
PC induced lipid droplet formation and found that, as in
C. elegans, co-depletion of PCTY1a with LPIN1 restored lipid
droplets to wild-type levels (Figures S4G–S4I). Taken together,
our results suggest that inhibiting LPIN1 expression or adding
its exogenous substrate can reverse the effects of PCYT1a
knockdown on SREBP-1.
Lipin 1 has been shown to inhibit SREBP-1 activity when
mTORC1-dependent (mechanistic Target of Rapamycin Com-plex) phosphorylation decreases and it localizes to the nucleus,
sequestering SREBP-1 at the nuclear membrane. However,
mechanisms linking low-PC SREBP-1 activation to Lipin 1
appear distinct. First, SREBP-1 nuclear localization after
PCTY1A or LPIN1 knockdown is nucleoplasmic and target genes
are activated (see also Walker et al., 2011). Second, localization
of endogenous Lipin 1 (Figures S5A and S5B; specificity
antibody shown in Figure S5C), or a transfected Flag-Lipin 1 (Fig-
ure S5D) is not changed after PCTY1A knockdown. Finally, frac-
tionation experiments show similar levels of Lipin 1 isoforms in
nuclear/ER and microsomal fractions in control and PCTY1a
extracts (Figure S5E). Lipin 1 may also act in co-activation of
b-oxidation genes (Reue and Zhang, 2008); however, these
genes are not altered upon PCYT1a depletion (Figure S5F).
Thus,mechanisms linking Lipin 1 and SREBP-1 in lowPC appear
distinct frommTORC1-mediated control of Lipin 1 localization or
direct effects on gene regulation.
PCTY1a and LPIN1 Knockdown Affect ARF1 Activity
Our previous studies found that low-PC or disruptions in ARF1
GEF (Guanine Exchange Factor) GBF1 induced maturation of
SREBP-1 (Walker et al., 2011), and our C. elegans screen also
implicated arf-1.2 in SBP-1 activation (Figures 1D, 1F, and 2A).
To determine whether this mechanism extended to mammalian
cells, we examined SREBP-1 localization and processing in
HepG2 cells after ARF1 siRNA and found that nuclear accumu-
lation increased and processed SREBP-1 appeared at higher
levels (Figures 3H–3J).
The validated hits from our C. elegans screen strongly impli-
cated enzymes that alter PA or DAG levels in low-PC mediated
processing of SREBP-1. Interestingly, both PA and DAG have
been reported to affect ARF1 function, interfering with COP I
transport (Asp et al., 2009; Ferna´ndez-Ulibarri et al., 2007; Mani-
fava et al., 2001). Therefore, we asked whether knockdown of
LPIN1 or PCYT1a affected levels of active, GTP-bound ARF1
and found that, strikingly, levelswerediminished inboth instances
(Figures 4A–4C). As in our previous assays, double knockdown of
LPIN1 andPCYT1a correcteddefects (Figures 4Dand4E). Finally,
we asked whether exogenous PA would phenocopy LPIN1
knockdown and rescue siPCYT1a effects on GTP-ARF levels
and found partial rescue of active ARF1 (Figures 4F and 4G).
Cytosolic membrane levels of PA (Csaki et al., 2013), DAG
(Sarri et al., 2011), or PC (Vance, 2014) could be affected in either
LPIN1 or PCYT1a knockdown. Interestingly, ARF1 activity de-
pends on membrane recruitment of the GTPase itself along
with membrane association of the GAP (GTPase Activating Pro-
tein, ARFGAP1) and GEF (GBF1) (Bankaitis et al., 2012; Lev,
2006; Spang, 2002). In addition, DAG levels may be important
for ARFGAP1 association (Antonny et al., 1997; Bigay et al.,
2003; Ferna´ndez-Ulibarri et al., 2007). Therefore, we compared
association of ARF1, GBF1, or ARFGAP1 with microsomal mem-
branes after PCYT1a or LPIN1 siRNA. Strikingly, GBF1 associa-
tion was broadly decreased, while ARFGAP1 and ARF1 did not
change (Figures 4H and 4I; Figures S5G and S5H). This suggests
that local changes in membrane lipids that occur after PCYT1a
or LPIN1 depletion may have profound effects on recruit-
ment GBF1, leading to disruptions in ARF1 activity activating
SREBP-1.Cell Reports 16, 9–18, June 28, 2016 13
Figure 3. siRNA Knockdown of LPIN1 Is Similar to PCYT1 Depletion, Increasing SREBP-1 Nuclear Accumulation in Human Cells
(A–C) Confocal projections of immunostaining of endogenous SREBP-1 (A) or immunoblots (B and C) showing accumulation of the nuclear, processed form after
siRNA of PCYT1a or LPIN1 in HepG2 cells. scr is the scrambled siRNA control, and yellow lines show cell boundaries. FL shows the full-length SREBP-1 pre-
cursor, and M is the mature, cleaved version.
(D and F) Confocal projections of HA-SREBP-1 levels after double knockdown of PCYT1 and LPIN1 in HepG2 cells (D) with quantitation in (F).
(E and G) Immunostaining and confocal projection of HepG2 cells shows increased nuclear accumulation of HA-SREBP-1 in cells treated with phosphatidic acid
(PA). PA treatment decreases nuclear HA-SREBP-1 in siPCYT1a knockdown cells. Quantitation is in (G).
(H and I) Endogenous SREBP-1 localization is shown by confocal projections of immunostaining (H) or by immunoblot (I) after treatment of HepG2 cells with siRNA
to ARF1. scr is scrambled control and yellow lines show cell outlines.
(J) Immunoblots show decrease in ARF1 after siRNA treatment. Number of cells are shown in parenthesis.
Results from Student’s t test shown by *p < 0.05, **p < 0.01, ***p < 0.005. Scale bars, 10 mm. See also Table S3 and Figures S4 and S5.
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Figure 4. Knockdown of Mammalian PCTY1 or LPIN1 Decreases ARF1 Activity
(A) Pull-down assays specific for GTP-bound ARF1 show significant decreases after LPIN1 or PCTY1a knockdown.
(B and C) Densitometry showing an average of three experiments for siLPIN1 or five experiments for siPCTY1a is shown in (B) and (C), respectively.
(D and E) Comparison of active ARF1 levels shown in a representative immunoblot (D) or by densitometry from immunoblots of the double knockdown of PCYT1a
and LPIN1 (E).
(F and G) Assessment of active ARF1 levels after PCYT1a siRNA or treatment with PA shown by immunoblot (F) or by densitometry (G).
(legend continued on next page)
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DISCUSSION
Lipid storage requires coordinated production of fatty acids,
phospholipids, TAGs, and other complex lipids (Horton et al.,
2002). Many of these lipids also function in membrane structure
or as signaling effectors, thus regulators of lipogenesis may
respond to various signals. Our screen identified lpin-1, a PA
phosphatase, (Takeuchi and Reue, 2009) as an activator of
SBP-1/SREBP-1. Although enzymatic activities of lipins sug-
gest straightforward synthetic functions, they have diverse roles
and broad physiological effects (Csaki et al., 2013). For
example, the fld mouse model of LPIN1 deficiency has meta-
bolic defects including fatty liver and lipodystrophy (Pe´terfy
et al., 2001) and the SREBP-1 transcriptional target SCD1 is up-
regulated (Chen et al., 2008). Lipin 1 has also been reported to
affect SREBP-1 activity through nuclear membrane sequestra-
tion (Peterson et al., 2011) or to act as a co-activator of b-oxida-
tion genes with PPARa (Finck et al., 2006); however, neither
of these activities was altered after PCYT1/CCTa knockdown.
In this context, we hypothesize Lipin 1-dependent effects on
SREBP-1 occur when changes in changes membrane lipids
alter membrane:protein interactions and activity of GBF-1 and
ARF-1.
Changes in PA, DAG, or PC within subcellular membranes
could have multiple effects. However, our data suggested a
connection to ARFs. Notably, several studies have found that
DAGs are important for ARF1 function or for recruiting ARFGAP
(Antonny et al., 1997; Bigay et al., 2003; Ferna´ndez-Ulibarri et al.,
2007; Randazzo and Kahn, 1994). However, we found that it
was the ARF-GEF, GBF1, that bound less well to membranes af-
ter PCYT1 or LPIN1 knockdown. Loss of GBF1 activates the
unfolded protein response and promotes cell death in mamma-
lian cells (Citterio et al., 2008) and defects in development and
Golgi integrity in C. elegans (Ackema et al., 2013). However,
larval growth arrest after gbf-1(RNAi) in our screen precluded
analysis. A recent study has suggested that GBF1 is recruited
to membranes in response to increases in ARF-GDP (Quilty
et al., 2014). We hypothesize that local changes in ratios of PA
to PC species or decreases in DAG species, as seen in our
studies of C. elegans microsomes, limit GBF1 recruitment and
prevent generation of GTP-bound ARF1. In this instance, there
could be insufficient DAG for recruitment or changes in curvature
predicted by a PA-rich membrane could disrupt membrane:pro-
tein interactions.
Finally, we have found that co-depletion of PC biosynthetic
enzymes and lpin-1/LPIN1 returns SBP-1/SREBP-1 function to
basal levels and restores TAG levels. In this case, inhibiting the
PA to DAG transition could limit both TAG and PC. We hypothe-
size this allows levels to rebalance, restoring ARF1 function and
baseline SBP-1/SREBP-1 activity. Thus, our results suggest
SBP-1/SREBP-1 transcriptional programs favoring lipogenesis
may be stimulated when the balance of PA, DAG, or PC change
within microsomal membranes.(H and I) Immunoblots of fractionated HepG2 cells comparing cytosolic (C) to micr
Calnexin shows membrane-associated fractions and b-actin confirms loading. F
expressing cells and represent three independent experiments.
Error bars show SD. Results from Student’s t test shown by *p < 0.05, **p < 0.01
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C. elegans: Strains and RNAi Constructs
Nematodes were cultured using standardC. elegansmethods. For information
on strains and RNAi constructs, see Table S3.
C. elegans: RNAi Screen
L1 larva were plated into 96-well plates arrayed with RNAi bacteria and scored
at the L4/young adult transition. Eachwell was given a score from3 to +3with
0 as no change in four independent replicates and scores were averaged. RNAi
cloneswhose average scores were >0.7 or <0.7 were selected as candidates
for validation.
C. elegans: GFP Visualization
pfat-7::GFP and SBP-1::GFP C. elegans strains were grown until the L4/young
adult transition, and images were acquired on a Leica SPE II confocal micro-
scope. All images were taken at identical gain settings within experimental
sets, and Adobe Photoshop was used for corrections to levels across exper-
imental sets.
C. elegans: Gene Expression Analysis
C. elegans at the L4/young adult transition were lysed and qRT-PCR analysis
was performed as in Ding et al. (2015). Primers are available upon request.
C. elegans: Lipid Analysis
C. elegans were grown on plates containing 30 mM choline until L2, washed,
and transferred to plates without choline until the second day of adulthood.
Sudan Black staining was performed as in Ding et al. (2015). Briefly, animals
were dehydrated in ethanol, stained with Sudan Black, placed on agar pads,
and photographed in bright-field microscopy with a Leica SPE II. Sudan Black
staining was quantitated by blind scoring of more then 30 for of small, medium,
or large lipid droplets. TAG levels were determined using a Triglyceride Color-
imetric Assay Kit (Cayman Chemical, 10010303) following manufacturer’s in-
structions. For quantitation of TAG levels, two-tailed Student’s t tests were
used to determine significance between three biological replicates. For lipido-
mic methods, see Supplemental Experimental Procedures.
Cell Culture: Media and Stable Cell Lines
HepG2 cells (ATCC, HB-8065) were maintained in Minimum Essential Medium
(Invitrogen) supplemented with 10% FBS (Invitrogen), glutamine (Invitrogen),
and sodium pyruvate (Invitrogen). HepG2 cells stably expressing human
SREBP-1c were generated by transfection of a pCMV6 SREBP-1c with an
N-terminal hemagglutinin (HA) epitope tag (Origene, RC208404) and selection
with Geneticin (Invitrogen).
Cell Culture: Transfection and siRNA
siRNA oligonucleotides were transfected for 48 hr with Lipofectamine
RNAiMAX Transfection Reagent (Invitrogen, 13778100) (see Table S3 for
specific siRNAs). Cells were incubated for 16 hr in 1% Lipoprotein Deficient
Serum (LDS) (Biomedical Technologies, BT907) and 25 mg/ml ALLN (Calbio-
chem) for 30 min prior to harvesting. For studies with co-depletion of PCYT1a
and LPIN1, equal amounts of each siRNA or targeting plus scrambled were
transfected.
Cell Culture: Gene Expression
Total mRNAwas extracted fromwith Tri-Reagent according to manufacturer’s
protocol (Sigma). qRT-PCR conditions were identical to C. elegans studies.
For qRT-PCR studies, graphs represent representative experiments selected
from at least three biological replicates. Two-tailed Student’s t tests were used
to compare significance between values with two technical replicates. Primer
sequences are available upon request.osomal (M) association of GBF1 or ARF1 after knockdown of PCYT1a or LPIN1.
or densitometry (I), values were normalized to vehicle-treated scrambled (scr)
, ***p < 0.005 compared to scrambled (scr) conditions. ns, not significant.
Lipid Vesicle Formation
Lipid vesicles containing 1,2-dipalmitoyl-sn-glycero-3-phosphate (PA) (Avanti
Polar Lipids, 830855P) were prepared by water bath sonication as in Zhang
et al. (2012) and added at final concentrations of 100 mM during the 16 hr incu-
bation in 1% LDS.
Immunofluorescence and Oil Red O Staining
Transfected cells were fixed in 3.7% paraformaldehyde and permeabilized in
0.5% NP-40 prior before blocking in 5% fetal bovine serum/ 0.1% NP-40 and
antibody treatment. For oil red O, cells were fixed with 3.7% paraformalde-
hyde, stained with oil red O (3 mg/ml in 60% isopropanol) for 10 min, and visu-
alized. For quantification of antibody staining or lipid droplets, ten individual
focal areas were photographed and then scored blind for high, medium, or
low nuclear accumulation (antibody) or analyzed using BioPix iQ 2.1.4 (drop-
lets). Two-tailed Student’s t tests were used to compare significance between
the ten photographed areas and are representative of three biological repli-
cates. All images within experimental sets were taken with a Leica SPE II at
identical confocal gain settings and Adobe Photoshop was used for levels
corrections.
Immunoblot Analysis
Cells were lysed by syringe in high-salt RIPA (50 mM Tris [pH 7.4]; 400 mM
NaCl; 0.1% SDS; 0.5% NaDeoxycholate; 1% NP-40; 1 mM DTT, 2.5 mg/ml
ALLN, Complete protease inhibitors [Roche]). Extracts were separated on
Invitrogen NuPage gels (4%–12%), transferred to nitrocellulose, and probed
with specified antibodies. Immune complexes were visualized with Luminol
Reagent (Millipore). Densitometry was performed by scanning of the film,
and then analysis of pixel intensity was performed with ImageJ software.
Graphs show average of at least three independent experiments with control
values normalized to one.
Cell Fractionation: HepG2
Transfected cells were resuspended in cold homogenization buffer (Micro-
some purification kit, Biovision) and dounced and then cleared briefly. Super-
natants were centrifuged at 80,000 3 g for 45 min. Pellets were collected
as microsomal fractions with the supernatant designated as the cytosolic
fraction.
Active Arf1 Analysis
Levels of active Arf1 were analyzed using an Active Arf1 Pull-Down and Detec-
tion Kit (Thermo Scientific) following manufacturer’s instructions. Densitom-
etry was performed by scanning of the film, and then analysis of pixel intensity
with ImageJ software was performed. Graphs show average of at least three
independent experiments with control values normalized to one.
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